Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, for instance, is buzzing as the shortest of short people leaves for the local schoolhouse and our official mascot is snoozing about. As for us, we are engaged in our usual routine of sipping cups of hot stimulation and foraging for interesting items. Meanwhile, here is your menu of tidbits to get started. Hope you conquer the world today and, of course, do stay in touch. …
Insys Therapeutics (INSY) agreed to pay $225 million to settle criminal and civil investigations into marketing practices of using kickbacks to persuade doctors to prescribe its Subsys painkiller, which contains fentanyl, a powerful and addictive opioid, STAT says. As part of the deal, an Insys subsidiary will plead guilty to five counts of mail fraud, while the company will pay a $2 million fine, $28 million in forfeitures, and $195 million to settle charges of violating the federal False Claims Act, which involves defrauding the federal government. The company must also sell the painkiller within a year.
About the Author Reprints
